Keyphrases
Retinal Injury
100%
Arginase
100%
Arginase Pathway
100%
Microglia
85%
Macrophage Activation
85%
Inducible Nitric Oxide Synthase
85%
Inflammation
71%
Neurovascular Injury
71%
Polyamine Metabolism
57%
Oxidative Stress
57%
Arginase 2
42%
Polyamine Pathway
42%
Neurovascular Degeneration
42%
In Vivo Imaging
28%
Polyamine Oxidation
28%
Molecular Mechanism
28%
Trauma Symptoms
28%
Effective Therapy
14%
Beneficial Effects
14%
Expected Outcomes
14%
Functional Outcome
14%
Neuronal Function
14%
Complex Interactions
14%
Ocular Trauma
14%
Treatment Efficacy
14%
Treatment Safety
14%
Successful Completion
14%
Specific Intent
14%
Mouse Model
14%
Vascular Function
14%
Neuronal Injury
14%
Traumatic Optic Nerve Injury
14%
Therapeutic Intervention
14%
Traumatic Injury
14%
Protective Effect
14%
Innovative Approach
14%
Permeability Barrier Function
14%
Lack of Understanding
14%
Peroxynitrite
14%
Neuron Cells
14%
Arginine
14%
Knockdown
14%
Structure Function
14%
Endothelial Nitric Oxide Synthase Uncoupling
14%
Knowledge Gaps
14%
Vasorelaxation
14%
Blindness
14%
Induced Activation
14%
Retinal Neurons
14%
Retinal Structure
14%
Retinal Vascular Network
14%
Well-being
14%
Ischemia
14%
Optic Nerve Injury
14%
Vascular Injury
14%
Novel Therapeutics
14%
Vascular Cells
14%
Ornithine
14%
Superoxide
14%
Oxidative Inflammation
14%
Medicine and Dentistry
Arginase
100%
Retina Injury
100%
Nitric Oxide Synthase
63%
Macrophage Activation
54%
Injury
54%
Microglia
54%
Polyamine
45%
Polyamine Metabolism
36%
Oxidative Stress
36%
Oxidizing Agent
18%
Optic Nerve Injury
18%
Arginine
9%
Reactive Oxygen Species
9%
Ornithine
9%
Superoxide
9%
Eye Injury
9%
Peroxynitrite
9%
Blood Vessel Injury
9%
Amaurosis
9%
Permeability Barrier
9%
Therapeutic Agent
9%
Ischemia
9%
Metabolism
9%
Wellbeing
9%
Retinal Neuron
9%
Combination Therapy
9%
Vasodilatation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Retina Injury
100%
Arginase
100%
Polyamine
81%
Nitric Oxide Synthase
63%
Inflammation
54%
Injury
54%
Oxidizing Agent
18%
Optic Nerve Injury
18%
Arginine
9%
Preclinical Study
9%
Ornithine
9%
Combination Therapy
9%
Ischemia
9%
Peroxynitrite
9%
Eye Injury
9%
Superoxide
9%
Mouse Model
9%
Blood Vessel Injury
9%